中华放射学杂志
中華放射學雜誌
중화방사학잡지
Chinese Journal of Radiology
2009年
10期
1102-1106
,共5页
陈双庆%王培军%李铭华%张炜%戴工华
陳雙慶%王培軍%李銘華%張煒%戴工華
진쌍경%왕배군%리명화%장위%대공화
间质干细胞%肝肿瘤%磁共振成像
間質榦細胞%肝腫瘤%磁共振成像
간질간세포%간종류%자공진성상
Mesenchymal stem cells%Liver neoplasms%Magnetic resonance imaging
目的 探讨磁标记大鼠骨髓间充质干细胞(BMSCs)活体内移植后对大鼠肝细胞癌的趋向性迁移及其机制.方法 培养大鼠BMSCs,超顺磁性氧化铁粒子标记.制备大鼠肝癌模型24只,数字表法随机分为3组:实验组(n=12)经脾植入磁标记的BMSCs;对照组A(n=6)移植未标记的BMSCs;对照组B(n=6)不作任何处理.分别于移植前及移植后1、3、7和14 d行MR扫描,选用T_2*WI序列进行移植细胞的示踪并测量肿瘤组织与正常肝组织的信号强度的比值(SI/SI*),结果行单因素方差分析;取肿瘤组织、瘤旁正常肝组织行普鲁士蓝染色,分析BMSCs在体内的分布并与MR对照.结果 BMSCs的磁标记率为90%以上.移植后实验组T_2*WI显示肿瘤信号强度值明显减低,移植前及移植后1、3、7和14 d的SI/SI*值分别为3.18±0.21、1.98±0.20、2.38±0.28、2.70±0.25及3.16±0.24,差异有统计学意义(F=56.65,P<0.05);与移植前相比,1、3、7 d肿瘤信号强度的减低有统计学意义(t值分别为1.20、0.79、0.48,P值均<0.05).对照组移植前后各SI/SI*值差异无统计学意义(P>0.05).免疫组织化学显示实验组肿瘤边缘及内部有大量监染的普鲁士蓝阳性细胞分布,标记细胞在肿瘤内的分布与MR信号改变基本一致.对照组肿瘤组织普鲁士蓝染色均为阴性结果.结论 BMSCs在活体内对肝癌细胞有明显的趋向迁移特性,有望成为基因治疗肝细胞癌的载体.
目的 探討磁標記大鼠骨髓間充質榦細胞(BMSCs)活體內移植後對大鼠肝細胞癌的趨嚮性遷移及其機製.方法 培養大鼠BMSCs,超順磁性氧化鐵粒子標記.製備大鼠肝癌模型24隻,數字錶法隨機分為3組:實驗組(n=12)經脾植入磁標記的BMSCs;對照組A(n=6)移植未標記的BMSCs;對照組B(n=6)不作任何處理.分彆于移植前及移植後1、3、7和14 d行MR掃描,選用T_2*WI序列進行移植細胞的示蹤併測量腫瘤組織與正常肝組織的信號彊度的比值(SI/SI*),結果行單因素方差分析;取腫瘤組織、瘤徬正常肝組織行普魯士藍染色,分析BMSCs在體內的分佈併與MR對照.結果 BMSCs的磁標記率為90%以上.移植後實驗組T_2*WI顯示腫瘤信號彊度值明顯減低,移植前及移植後1、3、7和14 d的SI/SI*值分彆為3.18±0.21、1.98±0.20、2.38±0.28、2.70±0.25及3.16±0.24,差異有統計學意義(F=56.65,P<0.05);與移植前相比,1、3、7 d腫瘤信號彊度的減低有統計學意義(t值分彆為1.20、0.79、0.48,P值均<0.05).對照組移植前後各SI/SI*值差異無統計學意義(P>0.05).免疫組織化學顯示實驗組腫瘤邊緣及內部有大量鑑染的普魯士藍暘性細胞分佈,標記細胞在腫瘤內的分佈與MR信號改變基本一緻.對照組腫瘤組織普魯士藍染色均為陰性結果.結論 BMSCs在活體內對肝癌細胞有明顯的趨嚮遷移特性,有望成為基因治療肝細胞癌的載體.
목적 탐토자표기대서골수간충질간세포(BMSCs)활체내이식후대대서간세포암적추향성천이급기궤제.방법 배양대서BMSCs,초순자성양화철입자표기.제비대서간암모형24지,수자표법수궤분위3조:실험조(n=12)경비식입자표기적BMSCs;대조조A(n=6)이식미표기적BMSCs;대조조B(n=6)불작임하처리.분별우이식전급이식후1、3、7화14 d행MR소묘,선용T_2*WI서렬진행이식세포적시종병측량종류조직여정상간조직적신호강도적비치(SI/SI*),결과행단인소방차분석;취종류조직、류방정상간조직행보로사람염색,분석BMSCs재체내적분포병여MR대조.결과 BMSCs적자표기솔위90%이상.이식후실험조T_2*WI현시종류신호강도치명현감저,이식전급이식후1、3、7화14 d적SI/SI*치분별위3.18±0.21、1.98±0.20、2.38±0.28、2.70±0.25급3.16±0.24,차이유통계학의의(F=56.65,P<0.05);여이식전상비,1、3、7 d종류신호강도적감저유통계학의의(t치분별위1.20、0.79、0.48,P치균<0.05).대조조이식전후각SI/SI*치차이무통계학의의(P>0.05).면역조직화학현시실험조종류변연급내부유대량감염적보로사람양성세포분포,표기세포재종류내적분포여MR신호개변기본일치.대조조종류조직보로사람염색균위음성결과.결론 BMSCs재활체내대간암세포유명현적추향천이특성,유망성위기인치료간세포암적재체.
Objective To label rat bone marrow mesenchymal stem cells with superparamagnetic iron oxide (SPIO) and to explore the tropism of BMSCs for hepatocellular carcinoma cells after transplantation in vivo. Methods BMSCs from bone marrow of Sprague-Dawly (SD) rats were cultured isolated and purified, Labeled BMSCs was achieved using Feridex. Twenty-four hepatocellular carcinoma models of SD rats were induced two weeks before tmnsplantation. The models were divided into three groups in random: the labeled BMSCs and unlabeled BMSCs were transplanted respectively into the rat's livers of experimental group (n = 12) and control group A(n =6) via spleens, and no transplant was done for control group B (n =6). MR imaging was performed to monitor the transplanted cells after 1,3,7,14 d using 1.5 T MR system. Signal intensity ratio (SI/SI*) between tumor and hepatic tissue on T_2 * WI were measured and compared by one-factor analysis of variance. After MR imaging, Prussian blue staining was performed. MR imaging findings were compared with histological sections. Results Prussian blue staining confirmed the labeling efficiency of BMSCs was above 90%. SI/SI* of experimental group before and 1, 3, 7, 14 d after transplantation were 3.18±0.21,1.98±0.20,2.38±0.28,2.70±0.25 and 3.16±0.24 respectively. Following transplantation of BMSCs, signal intensity decrease was found in hepatocellular carcinoma of experimental group(F =56.65,P <0.05) and low signal change decreased gradually and disappeared at two weeks after transplantation, while no remarkable low signal change was seen in the control group by T_2 * WI (P > 0.05). A large number of Prussian blue staining positive cells were found in hepatocellular carcinoma in experimental group. Histological section with Prussian blue staining had a good correlation with the signal intensity changes on MR images at different time. Conclusion BMSCs display significant tropism to hepatocellular carcinoma and may be an ideal gene therapy vehicle against hepatocellular carcinoma.